Prosight Management, LP Iovance Biotherapeutics, Inc. Transaction History

Prosight Management, LP

$372 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$6.38 - $18.33 $127,600 - $366,599	-20,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $604,144 - $932,080	-48,800 Reduced 70.93%	20,000 $333,000
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $3.41 Million - $5.69 Million	-205,961 Reduced 74.96%	68,800 $1.31 Million
Q3 2021 Nov 12, 2021	BUY	$20.35 - $26.63 $2.77 Million - $3.62 Million	135,875 Added 97.83%	274,761 $6.78 Million
Q2 2021 Aug 13, 2021	BUY	$16.33 - $33.07 $2.27 Million - $4.59 Million	138,886 New	138,886 $3.61 Million
Q4 2020 Feb 12, 2021	SELL	$28.04 - $50.26 $3.38 Million - $6.06 Million	-120,606 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$27.75 - $36.3 $2.62 Million - $3.43 Million	-94,394 Reduced 43.9%	120,606 $3.97 Million
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $9.2 Million - $13.9 Million	-338,100 Reduced 61.13%	215,000 $5.9 Million
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $3.21 Million - $6.39 Million	164,500 Added 42.33%	553,100 $16.6 Million
Q4 2019 Feb 14, 2020	BUY	$17.95 - $29.41 $761,995 - $1.25 Million	42,451 Added 12.26%	388,600 $10.8 Million
Q3 2019 Nov 14, 2019	SELL	$17.99 - $26.0 $968,779 - $1.4 Million	-53,851 Reduced 13.46%	346,149 $6.3 Million
Q2 2019 Aug 14, 2019	SELL	$9.78 - $24.52 $5.06 Million - $12.7 Million	-517,080 Reduced 56.38%	400,000 $9.81 Million
Q1 2019 May 15, 2019	SELL	$8.41 - $11.26 $1.22 Million - $1.64 Million	-145,420 Reduced 13.69%	917,080 $8.72 Million
Q4 2018 Feb 14, 2019	BUY	$7.51 - $11.93 $2.61 Million - $4.14 Million	347,183 Added 48.54%	1,062,500 $9.4 Million
Q3 2018 Nov 15, 2018	BUY	$11.25 - $17.7 $3.1 Million - $4.87 Million	275,417 Added 62.61%	715,317 $8.05 Million
Q2 2018 Aug 14, 2018	BUY	$12.45 - $16.95 $2.86 Million - $3.9 Million	230,058 Added 109.63%	439,900 $5.63 Million
Q1 2018 May 14, 2018	SELL	$8.1 - $19.5 $2.41 Million - $5.79 Million	-297,010 Reduced 58.6%	209,842 $3.55 Million
Q4 2017 Feb 13, 2018	BUY	$6.65 - $9.25 $3.37 Million - $4.69 Million	506,852	506,852 $4.06 Million

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

237M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.18B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.

Account